Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson’s Disease
Condition(s):Parkinson DiseaseLast Updated:May 7, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Parkinson DiseaseLast Updated:May 7, 2021Completed
Condition(s):Ménière’s DiseaseLast Updated:July 12, 2023Completed
Condition(s):Borderline Personality DisorderLast Updated:October 8, 2015Completed
Condition(s):Parkinson’s DiseaseLast Updated:August 9, 2023Completed
Condition(s):Bipolar DepressionLast Updated:October 28, 2014Terminated
Condition(s):Metastatic Castration-resistant Prostate Cancer; Adenocarcinoma of the ProstateLast Updated:October 14, 2020Recruiting
Condition(s):Major Depressive DisorderLast Updated:January 15, 2014Completed
Condition(s):Tobacco Use DisorderLast Updated:August 10, 2016Completed
Condition(s):Parkinson’s DiseaseLast Updated:October 31, 2014Completed
Condition(s):Tobacco Use CessationLast Updated:March 31, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.